Alamar Biosciences, Inc. (ALMR)
Nasdaq: ALMR · Laboratory Analytical Instruments · filing with the SEC since 2026
Who owns Alamar Biosciences, Inc.
As filed with the SECHolders of 5% or more
5
Qiming Corporate GP VI, Ltd holds 10.2% of Common stock, par value $0.0001 per share, as its SCHEDULE 13G filed Aug 11, 2026 says.
Directors and officers
10
report now, of 10 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Qiming Corporate GP VI, Ltd
SCHEDULE 13G · filed Aug 11, 2026 · Common stock, par value $0.0001 per share
Nicholas Naclerio
SCHEDULE 13D · filed Apr 23, 2026 · Common Stock, par value $0.0001 per share
Daqing Cai
SCHEDULE 13G · filed Jul 2, 2026 · Common Stock, par value $0.0001 per share
Yuling Luo
SCHEDULE 13G · filed Aug 13, 2026 · Common Stock
Sands Capital Life Sciences Pulse Fund II, L.P.
SCHEDULE 13D/A · filed Jul 7, 2026 · Common Stock, par value $0.0001 per share · 6.3% in Apr 23, 2026
What ALMR reports owning in othersstakes of 5% or more, and other ties
Alamar Biosciences, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$4.0Mbought, in dollars
Open-market trades on Form 4 from Nov 5, 2025 to Nov 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Qiming Corporate Gp Vi, Ltd. | 10% owner | 120 | $44.6M | 0 | 0 | $0 |
| Naclerio Nicholas | director | 0 | $0 | 0 | 1 | $4.0M |
| Illumina Innovation Fund II Gp, L.L.C. | 10% owner | 0 | $0 | 0 | 1 | $4.0M |